RxDoctor Payments Data

Roy Defrancis

Primary Podiatric Medicine · Cheektowaga, NYNPI 1346275351

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.2% of the total across 99 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Among primary podiatric medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,478in general payments, 2019–2025

Across 99 payments — averaging $45.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$707
  • Smith+Nephew$603
  • Paratek Pharmaceuticals, Inc.$479
  • Integra Lifesciences Corporation$430
  • Amgen$359
  • Bioventus LLC$203
  • plus $2K from 21 others

What the payments were for

  • Speaking & faculty fees$1253%
  • Food & beverage$4,35397%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,478 in reported general payments places this provider in the 90th percentile of 85 primary podiatric medicine providers in New York.

See all primary podiatric medicine providers in New York

Medicare billing

Part B allowed, 2024
$30,376
Medicare patients
134
Services billed
445

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen56$1,839
Ibuprofen76$833
Ammonium Lactate19$595
Ketoconazole16$470
Methocarbamol11$187
SsdSilver Sulfadiazine14$124
Cephalexin26$108
Terbinafine Hcl18$104
Methylprednisolone12$89
Oxycodone Hcl11$69

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Cheektowaga

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →